Regular consumption of vitamin C supplements linked to kidney stones risk: Study
Men who regularly take vitamin C supplements are at a higher risk of developing kidney stones, new data suggests.
Archives for February 7, 2013
Global sports nutrition market to top $6 billion by 2018, report says
Revamped, more complete product lines that are connecting with new customers are driving growth in the sports nutrition market, according to a new report.
Isoflavone supplements may reduce breast cancer risk
Women taking supplements containing isoflavones may have a lower risk of breast cancer, with high content supplements consistently linked with reduced risk, says a new analysis from Canada.
Buying botanical extracts: Is your purchasing model obsolete?
I'm relatively new to the botanicals industry, but I’ve been puzzled by the lack of attention that nutraceutical companies pay to the relationship between prices and harvest time.
Distributor offers only quercetin with GRAS status, official says
Novel Ingredients Services is now distributing what the company calls “the best quercetin available” after an agreement with manufacturer Quercegyn Pharmaceuticals. Continued growth in the sports nutrition market should boost application of the...
Dangerous drug-laced ‘Brazilian slimming coffee’ brand still sold in US
Despite a Food and Drug Administration (FDA) warning that a sibutramine-laced ‘Brazilian Slimming Coffee’ may pose a 'significant risk' to some US consumers, the product is still widely available online.
Nutrition NGO responds to COI attack: We cannot “continue to exclude business”
The Global Alliance for Improved Nutrition (GAIN) has defended its work with the global food industry, saying it is a vital partner in nutrition-changing efforts in the developing world and does not represent a conflict of interest (COI).
Probiotech and Microbiota 2013
Law veteran on EU health claim laws: “There is something quite wrong here.”
One of the EU’s most venerated food law experts stated the EU nutrition and health claims regulation (NHCR) has become so convoluted as to be unworkable, at a Brussels congress yesterday.
GSK not A-OK with Ribena, Lucozade? Strategic review begins…
GlaxoSmithKline (GSK) has launched a strategic review of its Lucozade and Ribena brands, hinting that the western-facing brands do not fit its increased focus on emerging markets such as China and India.